0001567619-19-017605.txt : 20190827
0001567619-19-017605.hdr.sgml : 20190827
20190827171955
ACCESSION NUMBER: 0001567619-19-017605
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190823
FILED AS OF DATE: 20190827
DATE AS OF CHANGE: 20190827
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Radov A. Jeffrey
CENTRAL INDEX KEY: 0001528040
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37603
FILM NUMBER: 191058432
MAIL ADDRESS:
STREET 1: 8 WALWORTH AVENUE
CITY: SCARSDALE
STATE: NY
ZIP: 10583
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BioRestorative Therapies, Inc.
CENTRAL INDEX KEY: 0001505497
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
IRS NUMBER: 911835664
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 40 MARCUS DRIVE
CITY: MELVILLE
STATE: NY
ZIP: 11747
BUSINESS PHONE: (631) 760-8100
MAIL ADDRESS:
STREET 1: 40 MARCUS DRIVE
CITY: MELVILLE
STATE: NY
ZIP: 11747
FORMER COMPANY:
FORMER CONFORMED NAME: Stem Cell Assurance, Inc.
DATE OF NAME CHANGE: 20101110
4
1
doc1.xml
FORM 4
X0306
4
2019-08-23
0
0001505497
BioRestorative Therapies, Inc.
BRTX
0001528040
Radov A. Jeffrey
8 WALWORTH AVENUE
SCARSDALE
NY
10583
1
0
0
0
Common Stock
2019-08-23
4
P
0
3000
0.2632
A
15500
D
Common Stock
2019-08-26
4
P
0
3000
0.25
A
18500
D
Stock Option
.75
2022-02-09
Common Stock
30000
30000
D
Stock Option
.75
2022-12-07
Common Stock
5000
5000
D
Stock Option
.75
2023-10-04
Common Stock
12500
12500
D
Stock Option
.75
2024-02-18
Common Stock
25000
25000
D
Stock Option
.75
2024-10-23
Common Stock
50000
50000
D
Stock Option
.75
2025-09-04
Common Stock
115500
115500
D
Stock Option
.75
2026-06-10
Common Stock
128000
128000
D
Stock Option
.75
2027-06-23
Common Stock
125000
125000
D
Stock Option
.75
2028-10-29
Common Stock
75000
75000
D
The option is exercisable to the extent of 15,000 shares on each of February 10, 2012 and February 10, 2013.
The option is exercisable to the extent of 2,500 shares on each of December 7, 2012 and December 7, 2013.
The option is exercisable to the extent of 6,250 shares on each of October 4, 2013 and October 4, 2014.
The option is exercisable to the extent of 8,334 shares on February 18, 2014, and 8,333 shares on each of February 18, 2015 and February 18, 2016.
The option is exercisable to the extent of 16,667 shares on each of October 23, 2015 and Octobe 23, 2016 and 16,666 shares on October 23, 2017.
The option is exercisable to the extent of 57,750 shares on December 22, 2015, and 19,250 shares on each of September 4, 2016, September 4, 2017 and September 4, 2018.
The option is exercisable to the extent of 42,667 shares on each of June 10, 2016 and June 10, 2017, and 42,666 shares on June 10, 2018.
The option is exercisable to the extent of 41,667 shares on each of June 23, 2017 and June 23, 2018, and 41,666 shares on June 23, 2019.
The option is exercisable to the extent of 25,000 shares on each of October 29, 2018, October 29, 2019 and October 29, 2020.
/s/ A. Jeffrey Radov
2019-08-27